Previous clinical studies have shown elevated OPG levels in patients with atherosclerosis and increased OPG levels with the severity of cardiovascular disease such as peripheral artery disease [33] and heart failure [34], with symptomatic carotid stenosis [35], unstable angina [36] and vulnerable carotid plaques [37]. This evidence concerns the gene TNFRSF11B and cardiovascular disorder.